ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.446
EU - Europa 2.018
AS - Asia 1.879
SA - Sud America 320
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 15
Totale 7.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.342
IT - Italia 745
SG - Singapore 491
CN - Cina 438
IE - Irlanda 254
GB - Regno Unito 242
BR - Brasile 221
VN - Vietnam 201
HK - Hong Kong 195
DE - Germania 173
BD - Bangladesh 161
SE - Svezia 153
FR - Francia 84
IN - India 76
RU - Federazione Russa 76
FI - Finlandia 71
CA - Canada 59
KR - Corea 52
ID - Indonesia 45
AR - Argentina 34
TR - Turchia 34
JP - Giappone 29
IQ - Iraq 27
EG - Egitto 26
LT - Lituania 26
NL - Olanda 26
MX - Messico 24
TW - Taiwan 23
UA - Ucraina 22
BG - Bulgaria 21
CO - Colombia 20
BE - Belgio 18
ES - Italia 18
MY - Malesia 18
PL - Polonia 18
PK - Pakistan 17
AU - Australia 15
CL - Cile 15
CZ - Repubblica Ceca 14
EC - Ecuador 13
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 10
AT - Austria 9
SA - Arabia Saudita 9
MD - Moldavia 8
MA - Marocco 7
VE - Venezuela 7
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
SY - Repubblica araba siriana 6
BH - Bahrain 4
DZ - Algeria 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
GA - Gabon 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
GD - Grenada 1
GT - Guatemala 1
HT - Haiti 1
Totale 7.744
Salva come PNG Salva come JPEG
Città #
Ashburn 469
Santa Clara 330
Singapore 279
Chandler 255
Dublin 251
San Jose 242
Hong Kong 187
Fairfield 179
Dallas 139
Council Bluffs 124
Beijing 108
Nyköping 99
Hefei 98
New York 89
Houston 78
Los Angeles 78
Southend 77
London 72
Milan 67
Woodbridge 67
Helsinki 64
Ann Arbor 63
Seattle 59
Ho Chi Minh City 58
Modena 57
Wilmington 49
Cambridge 48
Seoul 47
Bologna 45
The Dalles 45
Hanoi 40
Dearborn 39
Chicago 34
Jakarta 31
Munich 31
Rome 31
Fremont 29
Lauterbourg 28
Frankfurt am Main 26
Redwood City 26
Shanghai 26
Moscow 23
San Diego 23
Buffalo 22
Orem 22
Tokyo 22
Sofia 21
São Paulo 21
Princeton 20
Toronto 20
Baghdad 19
Asyut 18
Phoenix 18
Bremen 16
Parma 16
Portsmouth 16
Jacksonville 15
San Giuliano Milanese 15
Banqiao 14
Columbus 14
Mumbai 14
Reggio Emilia 14
Des Moines 13
Warsaw 13
Brooklyn 12
Brussels 12
Da Nang 12
Dong Ket 12
Haiphong 12
Lawrence 12
Eugene 11
Madrid 11
Nuremberg 11
Poplar 11
Sassuolo 11
Denver 10
Izmir 10
Mexico City 10
Atlanta 9
Belo Horizonte 9
Brno 9
Castelvetrano 9
Düsseldorf 9
Guangzhou 9
Paris 9
Absecon 8
Bari 8
Cardiff 8
Chennai 8
Chisinau 8
Genoa 8
Manchester 8
Montreal 8
Redondo Beach 8
Schiffdorf 8
Amsterdam 7
Charlotte 7
Melbourne 7
Porto Alegre 7
Quito 7
Totale 4.908
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 643
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 469
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 403
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 368
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 365
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 359
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 356
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 321
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 316
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 299
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 295
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 282
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 274
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 272
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 272
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 262
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 260
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 257
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 253
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 245
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 238
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 229
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 216
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 195
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 172
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 167
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer 26
Totale 7.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 0 33 28 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024605 28 25 51 65 59 75 76 57 33 30 53 53
2024/20251.493 45 18 36 104 273 202 129 111 166 103 118 188
2025/20262.873 198 79 270 256 376 163 358 149 241 284 237 262
2026/2027323 97 147 79 0 0 0 0 0 0 0 0 0
Totale 7.814